ARCHIVES

FDA: Oncology Division Director Delap Promoted In Agency

This article is from The Cancer Letter archive.

Vol. 24 No. 21 | May 29, 1998

Download PDF Visit The Full Archive

Related Articles

Waxman Subcommittee Hears Support For Cancer Act Renewal

March 7, 1980

A Low-Cost Vaccine To Enter Clinical Trials In A Year

September 24, 2010

In Brief: Van Andel Institute to Build Epigenetics Hub

February 28, 2014

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

January 8, 1982

FDA Subcommittee Leaning Toward Mouse-Dog Drug Testing New Preclinical Toxicity-Protocol

July 20, 1979